Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAVE NASDAQ:NVDA NYSE:SMR NASDAQ:TMDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAVEDave$202.88+1.3%$210.93$37.44▼$286.45$2.74B3.88498,834 shs293,356 shsNVDANVIDIA$185.04-0.3%$178.29$86.62▼$191.05$4.50T2.12231.00 million shs139.37 million shsSMRNuScale Power$39.18-6.6%$38.69$11.08▼$53.50$11.16B2.0212.58 million shs19.32 million shsTMDXTransMedics Group$115.18+1.1%$117.18$55.00▼$145.50$3.93B2.081.27 million shs867,902 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAVEDave-1.55%-5.02%+2.89%-23.58%+365.01%NVDANVIDIA-1.11%+2.03%+11.09%+15.96%+48.53%SMRNuScale Power+4.77%+10.27%+21.51%+19.56%+218.94%TMDXTransMedics Group-1.52%+1.15%+9.54%-8.66%-18.02%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAVEDave$202.88+1.3%$210.93$37.44▼$286.45$2.74B3.88498,834 shs293,356 shsNVDANVIDIA$185.04-0.3%$178.29$86.62▼$191.05$4.50T2.12231.00 million shs139.37 million shsSMRNuScale Power$39.18-6.6%$38.69$11.08▼$53.50$11.16B2.0212.58 million shs19.32 million shsTMDXTransMedics Group$115.18+1.1%$117.18$55.00▼$145.50$3.93B2.081.27 million shs867,902 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAVEDave-1.55%-5.02%+2.89%-23.58%+365.01%NVDANVIDIA-1.11%+2.03%+11.09%+15.96%+48.53%SMRNuScale Power+4.77%+10.27%+21.51%+19.56%+218.94%TMDXTransMedics Group-1.52%+1.15%+9.54%-8.66%-18.02%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAVEDave 2.80Moderate Buy$274.1335.12% UpsideNVDANVIDIA 2.96Moderate Buy$211.2614.17% UpsideSMRNuScale Power 2.07Hold$36.67-6.41% DownsideTMDXTransMedics Group 2.67Moderate Buy$125.408.87% UpsideCurrent Analyst Ratings BreakdownLatest TMDX, NVDA, DAVE, and SMR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/6/2025NVDANVIDIAThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$210.0010/3/2025NVDANVIDIACantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$240.0010/1/2025DAVEDaveBenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$320.009/30/2025NVDANVIDIAKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$230.00 ➝ $250.009/30/2025NVDANVIDIACitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$200.00 ➝ $210.009/30/2025SMRNuScale PowerBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Underperform$38.00 ➝ $34.009/29/2025SMRNuScale PowerBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageEqual Weight$45.009/29/2025NVDANVIDIAJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$205.00 ➝ $220.009/29/2025SMRNuScale PowerBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageEqual Weight$45.009/29/2025TMDXTransMedics GroupZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy9/27/2025DAVEDaveWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAVEDave$433.07M6.32$5.01 per share40.53$14.01 per share14.48NVDANVIDIA$165.22B27.22$3.02 per share61.36$3.25 per share56.94SMRNuScale Power$37.04M301.32$0.15 per share268.61$1.64 per share23.89TMDXTransMedics Group$531.29M7.39$1.64 per share70.31$6.81 per share16.91Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAVEDave$57.87M$3.7853.6769.72N/A12.74%33.02%19.94%11/11/2025 (Estimated)NVDANVIDIA$72.88B$3.5152.7246.491.3652.41%101.74%70.72%11/19/2025 (Estimated)SMRNuScale Power-$136.62M-$1.19N/AN/AN/A-221.07%2.61%2.03%11/6/2025 (Estimated)TMDXTransMedics Group$35.46M$1.9359.6880.55N/A13.49%28.02%8.64%10/27/2025 (Estimated)Latest TMDX, NVDA, DAVE, and SMR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/27/2025Q3 2025TMDXTransMedics Group$0.37N/AN/AN/A$145.33 millionN/A8/27/2025Q2 2026NVDANVIDIA$1.01$1.05+$0.04$1.08$45.65 billion$46.74 billion8/7/2025Q2 2025SMRNuScale Power-$0.1199-$0.13-$0.0101-$0.13$10.49 million$8.05 million7/30/2025Q2 2025TMDXTransMedics Group$0.48$0.92+$0.44$0.92$146.64 million$157.37 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDAVEDaveN/AN/AN/AN/AN/ANVDANVIDIA$0.040.02%N/A1.14%1 YearsSMRNuScale PowerN/AN/AN/AN/AN/ATMDXTransMedics GroupN/AN/AN/AN/AN/ALatest TMDX, NVDA, DAVE, and SMR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/27/2025NVDANVIDIAquarterly$0.010.02%9/11/20259/11/202510/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAVEDave0.359.519.51NVDANVIDIA0.084.213.60SMRNuScale PowerN/A4.224.22TMDXTransMedics Group1.619.869.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAVEDave18.01%NVDANVIDIA65.27%SMRNuScale Power78.37%TMDXTransMedics Group99.67%Insider OwnershipCompanyInsider OwnershipDAVEDave28.48%NVDANVIDIA4.17%SMRNuScale Power1.96%TMDXTransMedics Group7.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAVEDave25013.50 million9.65 millionOptionableNVDANVIDIA36,00024.30 billion23.29 billionOptionableSMRNuScale Power440284.88 million279.29 millionOptionableTMDXTransMedics Group21034.09 million31.70 millionOptionableTMDX, NVDA, DAVE, and SMR HeadlinesRecent News About These CompaniesGlobal Assets Advisory LLC Sells 12,550 Shares of TransMedics Group, Inc. $TMDXOctober 7 at 4:35 AM | marketbeat.comTransMedics Group Acquires Aircraft for Organ TransportOctober 6 at 10:34 PM | msn.comGC Wealth Management RIA LLC Makes New Investment in TransMedics Group, Inc. $TMDXOctober 2, 2025 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Raised to "Strong-Buy" at Zacks ResearchOctober 2, 2025 | americanbankingnews.comTransMedics Group (NASDAQ:TMDX) Upgraded by Zacks Research to Strong-Buy RatingOctober 1, 2025 | marketbeat.comPark Avenue Securities LLC Invests $445,000 in TransMedics Group, Inc. $TMDXSeptember 30, 2025 | marketbeat.comTaylor Frigon Capital Management LLC Trims Stock Position in TransMedics Group, Inc. $TMDXSeptember 29, 2025 | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) Receives $125.40 Average Target Price from AnalystsSeptember 28, 2025 | americanbankingnews.comTransMedics, Mercedes-Benz partner on organ transportation across ItalySeptember 26, 2025 | msn.comVoya Investment Management LLC Sells 2,890 Shares of TransMedics Group, Inc. $TMDXSeptember 26, 2025 | marketbeat.comIf You Invested $100 In TransMedics Group Stock 5 Years Ago, You Would Have This Much TodaySeptember 25, 2025 | benzinga.comTMDX Partners With Mercedes-Benz to Launch Organ Transport NetworkSeptember 25, 2025 | zacks.comTransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 25, 2025 | marketbeat.comHere's Why TransMedics (TMDX) is a Strong Growth StockSeptember 24, 2025 | zacks.comSilver Oak Securities Incorporated Purchases 2,823 Shares of TransMedics Group, Inc. $TMDXSeptember 23, 2025 | marketbeat.comTransMedics teams with Mercedes-Benz Group on organ transportation across ItalySeptember 22, 2025 | msn.comTransMedics, Mercedes team up on ground transportation network for organ transplants in ItalySeptember 22, 2025 | massdevice.comTransMedics: I'm More Bullish Than EverSeptember 22, 2025 | seekingalpha.comTransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in ItalySeptember 22, 2025 | prnewswire.comWhy TransMedics (TMDX) is a Top Momentum Stock for the Long-TermSeptember 19, 2025 | zacks.comTransMedics Group Hits 80-Plus Relative Strength Rating BenchmarkSeptember 19, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025Is Super Micro Next in Line for a Big AI Takeover?By Gabriel Osorio-Mazilli | September 23, 2025Dave & Buster’s Stock: Is Now the Time to Make a PLAY?By Thomas Hughes | September 17, 2025Micron’s Stock Price Rally Is Not Over: MU $190 Is Coming SoonBy Thomas Hughes | September 25, 2025NVIDIA Breaks Out to New Highs: What Comes Next?By Thomas Hughes | October 2, 2025TMDX, NVDA, DAVE, and SMR Company DescriptionsDave NASDAQ:DAVE$202.88 +2.60 (+1.30%) Closing price 04:00 PM EasternExtended Trading$203.25 +0.37 (+0.18%) As of 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.NVIDIA NASDAQ:NVDA$185.04 -0.50 (-0.27%) Closing price 04:00 PM EasternExtended Trading$185.38 +0.34 (+0.19%) As of 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.NuScale Power NYSE:SMR$39.18 -2.76 (-6.59%) Closing price 03:59 PM EasternExtended Trading$40.01 +0.83 (+2.11%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs. The company was founded in 2007 and is headquartered in Portland, Oregon. NuScale Power Corporation operates as a subsidiary of Fluor Enterprises, Inc.TransMedics Group NASDAQ:TMDX$115.18 +1.25 (+1.10%) Closing price 04:00 PM EasternExtended Trading$116.00 +0.82 (+0.71%) As of 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Dividend Aristocrats to Buy Before Year’s End Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Why Semtech Stock Is Rallying After Its NVIDIA Setback Marvell Insiders Buy Shares—Should Investors Follow Suit? TrumpRx Brings Pfizer Into the Green—Is It a Buy? Behind D-Wave's Massive Week (And Why Rivals Also Popped) Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
